Antipsychotics: Tardive tongue dyskinesia and burning mouth syndrome treated with botulinum toxin A: case report

By  

Reactions Weekly, Vol. 1, Iss. 1258, 2009-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Antidepressants/antipsychotics: Tardive dyskinesia (first report with tianeptine and reboxetine) in an elderly patient, treated with botulinum toxin A: case report

By  

Reactions Weekly, Vol. 1, Iss. 1348-1349, 2011-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines

By Ozdemir Vural   Aklillu Eleni   Mee Steven   Bertilsson Leif   Albers Lawrence J   Graham Janice E   Caligiuri Michael   Lohr James B   Reist Christopher  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 119-133

Informa Healthcare

Access to resources Recommend Favorite

The risk of tardive dyskinesia appears to be lower for olanzapine (2.5-20mg) than for conventional antipsychotics

By  

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Antipsychotics: Metabolic disorders, tardive dyskinesia and obsessive-compulsive symptoms (first report with ziprasidone): case report

By  

Reactions Weekly, Vol. 1, Iss. 1275, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite